نتائج البحث

Dosing patterns and dose effects of sacubitril/valsartan: A claims-based retrospective cohort study.

• Authors : Rung, Jillian M.¹ (AUTHOR) ; Barrett, Tyson S.¹ (AUTHOR); LeJeune, Keith^1,2 (AUTHOR)

Subjects: *MEDICAL care use; *MEDICAL care costs; *ENTRESTO

• Source: PLoS ONE. 3/25/2025, Vol. 20 Issue 3, p1-13. 13p.

تفاصيل العنوان

Bioequivalence Study to Compare Sacubitril and Valsartan Tablets (97mg/103mg) Versus Entresto® (Sacubitril and Valsartan) Tablets (97 mg/103 mg)

• Source: An Open Label, Balanced, Randomized, Single Dose, Two Treatment, Two Sequence, Four Period, Full-replicate, Oral Bioequivalence Study of Sacubitril and Valsartan 97

تفاصيل العنوان

Evaluating Dashboard-Integrated Pharmacist-Led Education on Improving Sacubitril/Valsartan Adherence in Heart Failure (PharmD ASSIST HFrEF)

• Source: Pharmacist-Led Education Through Interactive Visualization Dashboards for Adherence Support and Sustained Involvement in Sacubitril/Valsartan Therapy for Patients With

تفاصيل العنوان

Sacubitril-valsartan in Patients with Heart Failure with Reduced Ejection Fraction from Rural Tanzania

• Authors : Ifakara Health Institute, Tanzania; Martin Rohacek, Project Leader

• Source: Health Status After Switching Angiotensin-converting Enzyme Inhibitors or Angiotensin Receptor Blockers to Sacubitril-valsartan in Patients with Heart Failure with

تفاصيل العنوان

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

• Authors : Medical Research Agency, Poland

• Source: Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent

تفاصيل العنوان

Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC (PARACHUTE-HF)

• Source: A Multicenter, Prospective, Randomized, Open-label, Blinded-endpoint, Phase 4 Study to Evaluate the Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril

تفاصيل العنوان

Repurposing Valsartan May Protect Against Pulmonary Hypertension (REVAMP-PH)

• Authors : National Heart, Lung, and Blood Institute (NHLBI); Peter Leary, Associate Professor, School of Medicine

• Source: Repurposing Valsartan May Protect Against Pulmonary HypertensionLahm T, Hess E, Baron AE, Maddox TM, Plomondon ME, Choudhary G, Maron BA, Zamanian RT, Leary PJ.

تفاصيل العنوان

UV-Vis spectroscopy coupled with firefly algorithm-enhanced artificial neural networks for the determination of propranolol, rosuvastatin, and valsartan in ternary mixtures.

• Authors : Serag A; Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, 11751, Egypt. .; Abduljabbar MH

Subjects: Neural Networks, Computer* ; Valsartan*/Valsartan*/Valsartan*/analysis ; Rosuvastatin Calcium*/Rosuvastatin Calcium*/Rosuvastatin Calcium*/analysis

• Source: Scientific reports [Sci Rep] 2025 Mar 29; Vol. 15 (1), pp. 10838. Date of Electronic Publication: 2025 Mar 29.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

A Phase III Clinical Study of Valsartan Oral Solution for the Treatment of Hypertension in Children and Adolescents

• Source: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase III Study to Evaluate the Efficacy and Safety of Valsartan Oral Solution in Children and Adolescent

تفاصيل العنوان

Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan (TREAT-HF)

• Source: Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan (Treat HF)

تفاصيل العنوان